## NOC: Northrop Grumman Corporation - XLI: Industrials

### Executive Summary

STRENGTH thesis confirmed: MRS_10 at 5.3% in mid entry zone (3.0-6.0%), top quartile (88th pct) cross-sectional ranking. Short-term MRS_5 (4.5%) confirms momentum alignment. Strong momentum (+5.4% 5-day acceleration). Outperforming sector by 3.0%.

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($588.17)
- **If Wrong:** Exit if MRS_10 drops below entry zone or breaks stop
- **Invalidation:** MRS_10 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Assessing Northrop Grumman (NOC) Valuation As Key Defense Programs Draw Renewed Attention**
- Source: Simply Wall Street | 20260105T183441 | Somewhat-Bullish | Relevance: 100%
- Northrop Grumman (NOC) is gaining significant attention due to its involvement in key Pentagon programs, prompting an assessment of its valuation. While a popular narrative suggests an 11.6% undervaluation with a fair value of $662.68 due to robust defense cash flows and program ramps, a Discounted Cash Flow (DCF) model indicates potential overvaluation at a fair value of $512.83 against its current share price of $585.66. The article encourages investors to consider both perspectives and conduct their own research into the company's financial health, risks, and growth prospects.

**2. Who Will Build President Trump's New Golden Fleet Battleships?**
- Source: Finviz | 20260104T072700 | Somewhat-Bullish | Relevance: 83%
- President Trump plans to introduce a new "Trump-class" battleship, the USS Defiant, described as the most lethal surface combatant ever constructed, with an estimated cost of $9 billion or more. This article discusses the advanced weaponry this battleship will possess, including hypersonic missiles, electromagnetic railguns, and laser cannons. It also explores which major defense contractors like Huntington Ingalls Industries, General Dynamics, Boeing, Northrop Grumman, and RTX Corporation are likely to be involved in its construction.

**3. BWX Technologies (NYSE:BWXT) investors are up 3.6% in the past week, but earnings have declined over the last three years**
- Source: Simply Wall Street | 20260105T110836 | Neutral | Relevance: 65%
- BWX Technologies (NYSE:BWXT) investors have seen a 3.6% increase in the past week, contributing to a 217% share price rise over three years. Despite this, the company's earnings per share have declined by 0.5% annually over the same period. However, revenue growth of 10% per year and a 227% Total Shareholder Return (TSR) over three years, thanks in part to dividends, suggest other factors are driving investor sentiment.

**4. L3Harris Consolidates into Three Segments; Creates Dedicated Space & Mission Systems Unit**
- Source: SatNews Publishers | 20260105T210130 | Neutral | Relevance: 65%
- L3Harris Technologies has reorganized its business into three segments: Space & Mission Systems, Communications & Spectrum Dominance, and Missile Solutions, to align with "the future of warfare" and streamline national security missions. Concurrently, the company is divesting a 60% controlling stake in its Space Propulsion and Power Systems business to AE Industrial Partners for $845 million, while retaining full ownership of the critical RS-25 rocket engine program. This strategic move aims to enhance speed, technology, and commerciality for its defense customers.

**5. RTX stock jumps 2% as Iran headlines lift defense contractors â€” what to watch next week**
- Source: ts2.tech | 20260103T175400 | Somewhat-Bullish | Relevance: 62%
- RTX Corp (NYSE: RTX) shares rose 2.1% on Friday, closing at $187.25, driven by geopolitical tensions in Iran which also boosted broader defense stocks like Lockheed Martin and Northrop Grumman. Investors are now watching whether these tensions will lead to increased defense spending or simply add headline risk. Additionally, RTX faces commercial aerospace challenges with its Pratt & Whitney engines and has upcoming fourth-quarter earnings in late January, which will provide an update on its financial health and operational performance.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-16 | Morgan Stanley | $714 | $720 | -1% |
| 2025-12-15 | Alembic Global | $662 | $0 | 0% |
| 2025-12-12 | Citigroup | $654 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-16 | Morgan Stanley | main | Overweight |
| 2025-12-15 | Alembic Global | up | Overweight |
| 2025-12-12 | Citigroup | init | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.00M) |
| Sells | 2 ($0.05M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 49.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 9.5% (+0.8%)
- State Street Corpora: 9.3% (-1.6%)
- Capital Internationa: 8.2% (-1.7%)
- Blackrock Inc.: 6.9% (+1.0%)
- JPMORGAN CHASE & CO: 3.9% (+91.5%)

### Key Risks

1. Valuation stretched: PEG 3.7x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Momentum building: MRS_10 improving +5.4% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 3.69 signals overvaluation risk, limited margin of safety. Quality metrics strong (ROE 26%). Balance sheet: $1.3B free cash flow. Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $87.5B |
| Beta | 0.05 |
| 52W Range | $426.24 - $640.90 |
| Short Interest | 1.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.69 |
| Forward P/E | 21.2 |
| Current P/E | 23.5 |
| YoY Growth | 10.7% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -0.1% to 5.3% (+5.4% in 5 days), confirming momentum buildup. Currently in upper STRENGTH zone (3.0-6.0%), cross-sectional ranking at 88th percentile. MRS_5 at 4.5% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (3.57), confirming momentum. OFD pattern: +MTH (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 5.30% (CS: 89) | Strong |
| RSI_14 | 69.6 | Neutral |
| MACD Histogram | 3.57 | Bullish |
| vs SMA20 | 1.071x | Above |
| vs SMA50 | 1.071x | Above |
| vs SMA200 | 1.120x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $611.25
- **Stop Loss:** $588.17 (3.8% risk)
- **Target:** $645.87 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 59
- **Position Value:** $36,063.75
- **Portfolio %:** 36.06%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite. VIX remains calm at 14.9 (8th percentile) with positive yield curve (+65bps) and healthy breadth (59.2%), though elevated put/call ratio (1.27) suggests institutional hedging despite surface calm. Focus on quality with awareness of hedging activity divergence.*

### Earnings

**Next:** 2026-01-29 (Est: $6.95)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $6.46 | $7.67 | +18.8% |
| 2025Q2 | $6.80 | $8.15 | +19.9% |
| 2025Q1 | $6.26 | $3.32 | -47.0% |
| 2024Q4 | $6.35 | $6.39 | +0.7% |

---
*RULE-based L3 | 2026-01-07 09:36 | MRS_10*